Onyx Bridge Wealth Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Buy
4,931
+345
+8% +$45.5K 0.06% 210
2026
Q1
$639K Sell
4,586
-455
-9% -$63.7K 0.07% 184
2025
Q4
$619K Buy
5,041
+246
+5% +$29.9K 0.07% 194
2025
Q3
$532K Buy
4,795
+616
+15% +$70K 0.06% 209
2025
Q2
$463K Sell
4,179
-655
-14% -$69.7K 0.06% 177
2025
Q1
$542K Sell
4,834
-330
-6% -$34.1K 0.08% 151
2024
Q4
$477K Buy
5,164
+386
+8% +$34.8K 0.07% 161
2024
Q3
$401K Buy
4,778
+19
+0.4% +$1.45K 0.06% 184
2024
Q2
$327K Buy
4,759
+452
+10% +$30.2K 0.05% 195
2024
Q1
$282K Sell
4,307
-83
-2% -$6.38K 0.05% 198
2023
Q4
$356K Buy
4,390
+122
+3% +$9.49K 0.07% 169
2023
Q3
$320K Sell
4,268
-112
-3% -$8.62K 0.07% 167
2023
Q2
$338K Buy
4,380
+359
+9% +$28.6K 0.08% 163
2023
Q1
$334K Buy
4,021
+926
+30% +$76.7K 0.13% 117
2022
Q4
$273K Sell
3,095
-601
-16% -$47.6K 0.11% 132
2022
Q3
$242K Buy
+3,696
New +$233K 0.11% 131

Other funds holding GILD

Onyx Bridge Wealth Group's GILD Position: Q2 2026 in Review

Onyx Bridge Wealth Group increased its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, buying an estimated $45.5K and bringing the position to 4,931 shares worth $623K. The position accounts for 0.06% of the portfolio, ranked #210.

Onyx Bridge Wealth Group first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $639K in Q1 2026. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Onyx Bridge Wealth Group held 4,931 shares of Gilead Sciences worth $623K as of Q2 2026.
  • Onyx Bridge Wealth Group bought 345 Gilead Sciences shares in Q2 2026, an estimated $45.5K.
  • Gilead Sciences made up 0.06% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #210 holding.
  • Onyx Bridge Wealth Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
  • Onyx Bridge Wealth Group's Gilead Sciences position peaked at $639K in Q1 2026.
  • 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.